INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 133 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,493,000 | -58.6% | 32,071 | -49.3% | 0.01% | -65.7% |
| Q2 2022 | $3,608,000 | -39.8% | 63,201 | -35.5% | 0.04% | -35.2% |
| Q1 2022 | $5,992,000 | +427.0% | 97,925 | +351.0% | 0.05% | +440.0% |
| Q4 2021 | $1,137,000 | -45.4% | 21,715 | -83.5% | 0.01% | -94.7% |
| Q3 2017 | $2,083,000 | +313.3% | 131,980 | +325.9% | 0.19% | +272.5% |
| Q1 2017 | $504,000 | +9.6% | 30,989 | +161.0% | 0.05% | -50.5% |
| Q2 2016 | $460,000 | – | 11,871 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 640,000 | $25,626,000 | 6.33% |
| Redmile Group, LLC | 1,322,592 | $52,957,000 | 4.01% |
| SENZAR ASSET MANAGEMENT, LLC | 556,224 | $22,271,209,000 | 3.24% |
| RA Capital Management | 314,349 | $12,587,000 | 1.81% |
| WALL STREET ASSOCIATES | 205,657 | $8,235,000 | 1.58% |
| Parametrica Management Ltd | 5,400 | $216,000 | 1.36% |
| Rhenman & Partners Asset Management AB | 165,000 | $6,607,000 | 1.05% |
| EAM Investors, LLC | 95,168 | $3,811,000 | 0.60% |
| Rock Springs Capital Management LP | 180,000 | $7,207,000 | 0.58% |
| WASATCH ADVISORS LP | 1,085,973 | $43,482,000 | 0.58% |